Cover
Cover | Jan. 30, 2023 |
Cover [Abstract] | |
Document Type | 8-K/A |
Amendment Flag | true |
Amendment Description | This Amendment No. 1 to Current Report on Form 8-K/A (the “Amended Form 8-K”) amends and supplements the Current Report on Form 8-K filed by Predictive Oncology Inc. (the “Company”) on February 3, 2023 (the “Original Form 8-K”) to provide additional disclosure required by Instruction 2 to Item 5.02 of Form 8-K regarding the Company’s entry into an employment agreement with Pamela Bush, Ph.D., MBA. |
Document Period End Date | Jan. 30, 2023 |
Entity File Number | 001-36790 |
Entity Registrant Name | Predictive Oncology Inc. |
Entity Central Index Key | 0001446159 |
Entity Tax Identification Number | 33-1007393 |
Entity Incorporation, State or Country Code | DE |
Entity Address, Address Line One | 2915 Commers Drive |
Entity Address, Address Line Two | Suite 900 |
Entity Address, City or Town | Eagan |
Entity Address, State or Province | MN |
Entity Address, Postal Zip Code | 55121 |
City Area Code | (651) |
Local Phone Number | 389-4800 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common stock, $0.01 par value |
Trading Symbol | POAI |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |